[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1032047A1 - Process for the synthesis of hiv protease inhibitors - Google Patents

Process for the synthesis of hiv protease inhibitors

Info

Publication number
HK1032047A1
HK1032047A1 HK01102333A HK01102333A HK1032047A1 HK 1032047 A1 HK1032047 A1 HK 1032047A1 HK 01102333 A HK01102333 A HK 01102333A HK 01102333 A HK01102333 A HK 01102333A HK 1032047 A1 HK1032047 A1 HK 1032047A1
Authority
HK
Hong Kong
Prior art keywords
synthesis
protease inhibitors
hiv protease
hiv
inhibitors
Prior art date
Application number
HK01102333A
Other languages
English (en)
Inventor
Emile Al-Farhan
David D Deininger
Stephen Mcghie
John O'callaghan
Mark Stuart Robertson
Keith Rodgers
Stephen John Rout
Hardev Singh
Roger Dennis Tung
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HK1032047A1 publication Critical patent/HK1032047A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HK01102333A 1998-03-20 2001-03-30 Process for the synthesis of hiv protease inhibitors HK1032047A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9805898.5A GB9805898D0 (en) 1998-03-20 1998-03-20 Process for the sythesis of hiv protease inhibitors
PCT/GB1999/000852 WO1999048885A1 (en) 1998-03-20 1999-03-18 Process for the synthesis of hiv protease inhibitors

Publications (1)

Publication Number Publication Date
HK1032047A1 true HK1032047A1 (en) 2001-07-06

Family

ID=10828884

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01102333A HK1032047A1 (en) 1998-03-20 2001-03-30 Process for the synthesis of hiv protease inhibitors

Country Status (32)

Country Link
US (1) US6281367B1 (xx)
EP (1) EP1066276B1 (xx)
JP (1) JP3363439B2 (xx)
KR (1) KR100555278B1 (xx)
CN (1) CN1308319C (xx)
AP (1) AP1226A (xx)
AT (1) ATE242772T1 (xx)
AU (1) AU751534B2 (xx)
BR (1) BR9908970A (xx)
CA (1) CA2324217C (xx)
CZ (1) CZ299193B6 (xx)
DE (1) DE69908761T2 (xx)
DK (1) DK1066276T3 (xx)
EA (1) EA003022B1 (xx)
EE (1) EE04750B1 (xx)
ES (1) ES2203090T3 (xx)
GB (1) GB9805898D0 (xx)
HK (1) HK1032047A1 (xx)
HR (1) HRP20000609B1 (xx)
HU (1) HUP0105439A3 (xx)
ID (1) ID26587A (xx)
IL (1) IL138127A (xx)
IS (1) IS2273B (xx)
NO (1) NO317648B1 (xx)
NZ (1) NZ506563A (xx)
PL (1) PL201810B1 (xx)
PT (1) PT1066276E (xx)
RS (1) RS49954B (xx)
SK (1) SK283939B6 (xx)
TR (1) TR200002698T2 (xx)
WO (1) WO1999048885A1 (xx)
ZA (1) ZA200004482B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0656887T3 (da) 1992-08-25 1999-07-05 Searle & Co Hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
EP1244610B1 (en) * 1999-12-23 2008-07-16 Ampac Fine Chemicals LLC Improved preparation of 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
US6548706B2 (en) * 1999-12-23 2003-04-15 Aerojet Fine Chemicals Llc Preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl) -p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
EP2314591B2 (en) * 2002-05-16 2021-02-24 Janssen Sciences Ireland Unlimited Company Pseudopolymorphic forms of a hiv protease inhibitor
RS51073B (sr) * 2003-12-23 2010-10-31 Tibotec Pharmaceuticals Ltd. Proces za pripremanje (3r,3as,6ar)-heksahidrofuro│2,3-b│ furan-3-il (1s,2r)-3-││(4-aminofenil) sulfonil│(izobutil) amino │-1-benzil-2-hidroksipropilkarbamata
TWI482775B (zh) 2008-09-01 2015-05-01 Tibotec Pharm Ltd 用於製備（３ｒ，３ａｓ，６ａｒ）－六氫呋喃并〔２，３－ｂ〕呋喃－３－基（１ｓ，２ｒ）－３－〔〔（４－胺基苯基）磺醯基〕（異丁基）胺基〕－１－苯甲基－２－羥基丙基胺基甲酸酯之方法
PE20160180A1 (es) 2010-01-27 2016-05-04 Viiv Healthcare Co Combinaciones de compuestos que comprenden inhibidores de la integrasa de vih y otros agentes terapeuticos.
US8877947B2 (en) 2010-09-10 2014-11-04 Lupin Limited Process for preparation of substantially pure fosamprenavir calcium and its intermediates
CN111233794A (zh) * 2020-03-27 2020-06-05 江巨东 一种安普那韦的精制方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1071930A (zh) * 1991-07-10 1993-05-12 伊莱利利公司 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂
DK0656887T3 (da) * 1992-08-25 1999-07-05 Searle & Co Hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease

Also Published As

Publication number Publication date
ID26587A (id) 2001-01-18
CA2324217A1 (en) 1999-09-30
GB9805898D0 (en) 1998-05-13
CA2324217C (en) 2008-02-19
AP1226A (en) 2003-11-21
HUP0105439A3 (en) 2002-08-28
IL138127A0 (en) 2001-10-31
JP3363439B2 (ja) 2003-01-08
PT1066276E (pt) 2003-10-31
DK1066276T3 (da) 2003-10-06
EP1066276A1 (en) 2001-01-10
CN1308319C (zh) 2007-04-04
IS2273B (is) 2007-07-15
DE69908761D1 (de) 2003-07-17
EE200000568A (et) 2002-02-15
DE69908761T2 (de) 2004-02-19
NZ506563A (en) 2003-05-30
US6281367B1 (en) 2001-08-28
ZA200004482B (en) 2001-11-28
NO317648B1 (no) 2004-11-29
IS5605A (is) 2000-08-29
KR100555278B1 (ko) 2006-03-03
CN1293668A (zh) 2001-05-02
EA200000859A1 (ru) 2001-04-23
AU2947599A (en) 1999-10-18
JP2002507609A (ja) 2002-03-12
EA003022B1 (ru) 2002-12-26
KR20010042022A (ko) 2001-05-25
PL342602A1 (en) 2001-06-18
NO20004664L (no) 2000-09-19
BR9908970A (pt) 2000-11-28
EP1066276B1 (en) 2003-06-11
YU55900A (sh) 2003-02-28
CZ299193B6 (cs) 2008-05-14
SK283939B6 (sk) 2004-05-04
AU751534B2 (en) 2002-08-22
HRP20000609B1 (en) 2006-05-31
SK13732000A3 (sk) 2001-08-06
ATE242772T1 (de) 2003-06-15
EE04750B1 (et) 2006-12-15
AP2000001911A0 (en) 2000-09-30
ES2203090T3 (es) 2004-04-01
CZ20003457A3 (cs) 2001-04-11
RS49954B (sr) 2008-09-29
TR200002698T2 (tr) 2000-12-21
PL201810B1 (pl) 2009-05-29
HUP0105439A2 (en) 2002-06-29
WO1999048885A1 (en) 1999-09-30
IL138127A (en) 2003-10-31
NO20004664D0 (no) 2000-09-19
HRP20000609A2 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
AU3662799A (en) Processes for the synthesis of oligomeric compounds
PL342113A1 (en) Sulphonamidic derivatives useful as precursors of aspartil protease inhibitors
AU1601100A (en) Improved processes for the synthesis of oligomeric compounds
EG22541A (en) Process for the production of olefins
HUP0105439A2 (en) Process for the synthesis of hiv protease inhibitors
GB9905422D0 (en) Process for the production of olefins
GB9515802D0 (en) Hiv protease inhibitors useful for the treatment of aids
ZA98898B (en) Process for the production of halogeno-o-hydroxydiphenyl compounds
EP0785786A4 (en) MICROBIAL SYNTHESIS OF HIV PROTEASE INHIBITORS
HK1052350A1 (zh) 一種合成嗎啉基苯類化合物的新方法
IL138843A0 (en) Improved process for the manufacture of n- (1-cyanoalkyl) -2-phenoxypropionamide derivatives
SI1066276T1 (en) Process for the synthesis of hiv protease inhibitors
IL124178A (en) Process for the production of distryryl-biphenyl compounds
EP0912170A4 (en) HIV PROTEASE INHIBITORS USEFUL IN AIDS TREATMENT
EP0785989A4 (en) MICROBIAL SYNTHESIS OF INHIBITORS OF THE HIV PROTEASE
HUP0203214A3 (en) Process for preparing intermediates applicable for synthesis of hiv protease inhibitor
EP0914125A4 (en) HIV protease inhibitors, useful in AIDS treatment.
HUP0103105A3 (en) Process for the synthesis of exochelins
GC0000365A (en) Process for the production of olefins
GB9825179D0 (en) Process for the removal of organometallic materials
HK1034064A1 (en) Process for the production of formylimidazoles
AU3515700A (en) Process for the synthesis of dihydropyridones
GB9613487D0 (en) HIV protease inhibitors useful for the treatment of aids
GB9609663D0 (en) HIV Protease inhibitors useful for the treatment of aids
AU5775200A (en) Versatile method for the synthesis of iso-dtpa

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100318